Robert Oldham

8PUBLICATIONS
63CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 15, 2026
Anti-TNFR2 antibody BI-1808 induces tumor regression and antitumor T cell immunity through T reg and myeloid cell modulation in patients with solid tumors.

|Oct 10, 2025
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.

Javier Cortés, Araceli Priego, Elena Garralda

|Sep 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

Kirstie L S Cleary, Monika Semmrich, Linda Martensson

|Sep 03, 2021
On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation.

Joshua M Sopp, Shirley J Peters, Tania F Rowley

|Nov 20, 2020
Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment.

Rena Liu, Robert J Oldham, Emma Teal

|Jun 20, 2020
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.

Robert J Oldham, C Ian Mockridge, Sonya James

Pageof 2

Frequent Collaborators

6 joint publications

Mark S Cragg

3 joint publications

Linda Martensson

3 joint publications

Ingrid Teige

3 joint publications

Bjorn Frendeus